Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Epigenetic therapy in hematological cancers

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{77f2ccddf84041419d28dd80158a95d8,
title = "Epigenetic therapy in hematological cancers",
abstract = "The increasing depth of knowledge about cancer biology throughout the last decades, has underlined the importance of not only genetic aberrations, but also epigenetic abnormalities in cancer cells. The extensive exploration of the cancer epigenome has provided insights into key pathways involved in tumorigenesis, as well as has allowed the development of novel epigenetic therapies. In this review, we will present the important role of epigenetic alterations in hematological diseases, with special focus on epigenetically-based targeting of hematological malignancies.",
keywords = "DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors, DNA Methylation, Epigenesis, Genetic, Hematologic Neoplasms/drug therapy, Histone Deacetylase Inhibitors/therapeutic use, Histones/metabolism, Humans",
author = "Konstantinos Dimopoulos and Kirsten Gr{\o}nbaek",
note = "{\circledC} 2019 APMIS. Published by John Wiley & Sons Ltd.",
year = "2019",
month = "5",
day = "12",
doi = "10.1111/apm.12906",
language = "English",
volume = "127",
pages = "316--328",
journal = "APMIS - Journal of Pathology, Microbiology and Immunology",
issn = "0903-4641",
publisher = "Wiley Online",
number = "5",

}

RIS

TY - JOUR

T1 - Epigenetic therapy in hematological cancers

AU - Dimopoulos, Konstantinos

AU - Grønbaek, Kirsten

N1 - © 2019 APMIS. Published by John Wiley & Sons Ltd.

PY - 2019/5/12

Y1 - 2019/5/12

N2 - The increasing depth of knowledge about cancer biology throughout the last decades, has underlined the importance of not only genetic aberrations, but also epigenetic abnormalities in cancer cells. The extensive exploration of the cancer epigenome has provided insights into key pathways involved in tumorigenesis, as well as has allowed the development of novel epigenetic therapies. In this review, we will present the important role of epigenetic alterations in hematological diseases, with special focus on epigenetically-based targeting of hematological malignancies.

AB - The increasing depth of knowledge about cancer biology throughout the last decades, has underlined the importance of not only genetic aberrations, but also epigenetic abnormalities in cancer cells. The extensive exploration of the cancer epigenome has provided insights into key pathways involved in tumorigenesis, as well as has allowed the development of novel epigenetic therapies. In this review, we will present the important role of epigenetic alterations in hematological diseases, with special focus on epigenetically-based targeting of hematological malignancies.

KW - DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors

KW - DNA Methylation

KW - Epigenesis, Genetic

KW - Hematologic Neoplasms/drug therapy

KW - Histone Deacetylase Inhibitors/therapeutic use

KW - Histones/metabolism

KW - Humans

U2 - 10.1111/apm.12906

DO - 10.1111/apm.12906

M3 - Review

VL - 127

SP - 316

EP - 328

JO - APMIS - Journal of Pathology, Microbiology and Immunology

JF - APMIS - Journal of Pathology, Microbiology and Immunology

SN - 0903-4641

IS - 5

ER -

ID: 57443452